Home/Filings/4/0001567619-20-000293
4//SEC Filing

Bejar Rafael 4

Accession 0001567619-20-000293

CIK 0000882361other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:00 PM ET

Size

5.7 KB

Accession

0001567619-20-000293

Insider Transaction Report

Form 4
Period: 2020-01-01
Bejar Rafael
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-01-01+400,0000 total
    Exercise: $5.67Exp: 2030-12-31Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]Fifty percent (50%) of the options vest on 1/1/2021; the remaining 50% vest as follows: 1/3 on 1/1/2022; 1/3 on 1/1/2023; and 1/3 on 1/1/2024.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001797382

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:00 PM ET
Size
5.7 KB